z-logo
open-access-imgOpen Access
Molecular biology of angiotensinogen.
Author(s) -
Kevin R. Lynch,
M J Peach
Publication year - 1991
Publication title -
hypertension
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.986
H-Index - 265
eISSN - 1524-4563
pISSN - 0194-911X
DOI - 10.1161/01.hyp.17.3.263
Subject(s) - medicine , plasma renin activity , renin–angiotensin system , endocrinology , blood pressure
A ngiotensinogen is a moderately abundant / \ 55,000-60,000 Da serum glycoprotein that is -Z \ the precursor to the angiotensin peptides and is the only known naturally occurring renin substrate. It is synthesized by a variety of cells, most prominently hepatocytes, adipocytes, and astrocytes. Most angiotensinogen is extracellular (it is constitutively secreted); thus, there is apparently no way that an organism can orchestrate rapid changes in angiotensinogen concentration. The angiotensinogen gene is regulated by several hormones (e.g., glucocorticoid and estrogen), and angiotensinogen is an acute-phase protein. Angiotensinogen is a member of the serpin gene superfamily, but there is little reason to suppose that this protein is a serine protease inhibitor. The available evidence indicates that angiotensinogen functions solely as an extracellular reservoir of angiotensin peptides. In this article, we attempt a critical review of the literature on the biology of this protein, with an emphasis on recent molecular biological studies. We recommend other recent reviews, for example, those of Tewksbury or Campbell, for alternative views of this subject matter.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom